Total Payments
$38,464
2024 Payments
$4,288
Companies
72
Transactions
733
Medicare Patients
14,426
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$21,083 (54.8%)
Travel$8,744 (22.7%)
Other$8,333 (21.7%)
Consulting$200.00 (0.5%)
Education$103.54 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,083 | 696 | 54.8% |
| Travel and Lodging | $8,744 | 29 | 22.7% |
| Grant | $8,333 | 1 | 21.7% |
| Consulting Fee | $200.00 | 1 | 0.5% |
| Education | $103.54 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $10,304 | 53 | $0 (2024) |
| Abbott Laboratories | $3,156 | 77 | $0 (2024) |
| Vertiflex, Inc. | $2,510 | 30 | $0 (2019) |
| Relievant Medsystems, Inc. | $2,382 | 26 | $0 (2023) |
| MML US, Inc. | $2,321 | 13 | $0 (2023) |
| Nevro Corp. | $2,136 | 41 | $0 (2024) |
| Vertos Medical, Inc. | $1,617 | 14 | $0 (2024) |
| Medtronic USA, Inc. | $1,292 | 11 | $0 (2020) |
| Spinal Simplicity, LLC | $1,169 | 2 | $0 (2021) |
| ABBVIE INC. | $1,024 | 50 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,288 | 157 | PAINTEQ LLC ($647.36) |
| 2023 | $2,443 | 101 | UCB, Inc. ($260.76) |
| 2022 | $4,739 | 92 | MML US, Inc. ($2,197) |
| 2021 | $4,083 | 95 | Spinal Simplicity, LLC ($1,169) |
| 2020 | $3,111 | 66 | Relievant Medsystems, Inc. ($1,242) |
| 2019 | $7,072 | 163 | Vertiflex, Inc. ($2,510) |
| 2018 | $3,824 | 54 | Abbott Laboratories ($1,571) |
| 2017 | $8,904 | 5 | BOSTON SCIENTIFIC CORPORATION ($8,802) |
All Payment Transactions
733 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: Not Applicable | ||||||
| 12/19/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: Genetic Disease | ||||||
| 12/11/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Not Applicable | ||||||
| 12/10/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $4.98 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/27/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $100.62 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/21/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $56.57 | General |
| Category: PAIN MANAGEMENT | ||||||
| 11/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $34.79 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $12.23 | General |
| 11/21/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: Not Applicable | ||||||
| 11/20/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $134.93 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/15/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $162.50 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.70 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: Not Applicable | ||||||
| 11/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Neuromodulation | ||||||
| 10/30/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $4.00 | General |
| Category: Not Applicable | ||||||
| 10/29/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $34.13 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/29/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $2.16 | General |
| 10/18/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Neuroscience | ||||||
| 10/17/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Genetic Disease | ||||||
| 10/16/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Not Applicable | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 2,580 | 7,682 | $5.1M | $451,711 |
| 2022 | 37 | 3,335 | 9,987 | $1.7M | $436,775 |
| 2021 | 36 | 3,982 | 6,434 | $2.4M | $616,816 |
| 2020 | 39 | 4,529 | 14,282 | $2.2M | $615,824 |
Total Patients
14,426
Total Services
38,385
Medicare Billing
$2.1M
Procedure Codes
139
All Medicare Procedures & Services
139 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 460 | 460 | $202,400 | $60,576 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 334 | 576 | $144,000 | $59,401 | 41.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 215 | 252 | $872,161 | $55,464 | 6.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 90 | 165 | $707,505 | $33,431 | 4.7% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 36 | 39 | $454,339 | $32,194 | 7.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 228 | 337 | $56,953 | $24,818 | 43.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 84 | 153 | $424,662 | $24,670 | 5.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 47 | 48 | $442,085 | $24,303 | 5.5% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 86 | 156 | $327,004 | $16,650 | 5.1% |
| 64628 | Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones | Facility | 2023 | 39 | 41 | $230,179 | $16,464 | 7.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 73 | 76 | $49,020 | $16,055 | 32.8% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 33 | 64 | $288,156 | $13,507 | 4.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 46 | 49 | $168,008 | $13,187 | 7.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 121 | 126 | $149,753 | $11,833 | 7.9% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 19 | 25 | $174,834 | $10,517 | 6.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 83 | 83 | $23,738 | $7,500 | 31.6% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 33 | 64 | $136,686 | $7,025 | 5.1% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 29 | 33 | $21,747 | $6,897 | 31.7% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 18 | 24 | $80,016 | $6,012 | 7.5% |
| 64629 | Heat destruction of intraosseous basivertebral nerve in additional bone of spine in lower back | Facility | 2023 | 20 | 20 | $53,800 | $3,791 | 7.0% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 27 | 33 | $40,784 | $2,875 | 7.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 34 | 34 | $3,468 | $1,495 | 43.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 20 | $4,053 | $1,041 | 25.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 11 | 11 | $2,357 | $747.60 | 31.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 114 | 673 | $2,692 | $561.20 | 20.8% |
About Dr. Ivan Samcam, MD
Dr. Ivan Samcam, MD is a Interventional Pain Medicine healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2014. The National Provider Identifier (NPI) number assigned to this provider is 1194131730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Samcam, MD has received a total of $38,464 in payments from pharmaceutical and medical device companies, with $4,288 received in 2024. These payments were reported across 733 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($21,083).
As a Medicare-enrolled provider, Samcam has provided services to 14,426 Medicare beneficiaries, totaling 38,385 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 139 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Pain Medicine
- Other Specialties Emergency Medicine
- Location Naples, FL
- Active Since 07/03/2014
- Last Updated 12/05/2025
- Taxonomy Code 208VP0014X
- Entity Type Individual
- NPI Number 1194131730
Products in Payments
- PRECISION (Device) $8,770
- Superion ISS (Device) $2,510
- Intracept (Device) $2,413
- ReActiv8 (Device) $2,321
- Senza Spinal Cord Stimulation System (Device) $1,722
- mild Device Kit (Device) $1,617
- HA MINUTEMAN G3-R (Device) $1,169
- Proclaim Family of SCS IPGs (Device) $1,071
- Axium INS DRG IPG (Device) $970.49
- ADAPTIVESTIM (Device) $781.92
- BOTOX (Biological) $703.13
- PAINTEQ (Device) $689.30
- Proclaim IPG (Device) $463.11
- INTELLIS (Device) $452.74
- Leqembi (Drug) $449.25
- StimQ Receiver Stimulator Kit Channel A US w/Receiver (Device) $428.02
- Briviact (Drug) $388.28
- UBRELVY (Drug) $377.70
- NURTEC ODT (Drug) $346.38
- XTAMPZA (Drug) $345.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.